These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 33044550

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Angiotensin Receptor Blockers for Hypertension and Risk of Epilepsy.
    Wen X, Otoo MN, Tang J, Brothers T, Ward KE, Asal N, Meador KJ.
    JAMA Neurol; 2024 Aug 01; 81(8):866-874. PubMed ID: 38884986
    [Abstract] [Full Text] [Related]

  • 5. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
    Mayyas F, Bataineh W, Jarab A.
    Endocr Pract; 2017 Nov 01; 23(11):1289-1296. PubMed ID: 28816537
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19.
    Rizk JG, Wenziger C, Tran D, Hashemi L, Moradi H, Streja E, Ahluwalia A.
    Drugs; 2022 Jan 01; 82(1):43-54. PubMed ID: 34914085
    [Abstract] [Full Text] [Related]

  • 7. Renin-Angiotensin-Aldosterone System Blockade after AKI with or without Recovery among US Veterans with Diabetic Kidney Disease.
    Murphy DP, Wolfson J, Reule S, Johansen KL, Ishani A, Drawz PE.
    J Am Soc Nephrol; 2023 Oct 01; 34(10):1721-1732. PubMed ID: 37545022
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes Care.
    Hurwitz JT, Grizzle AJ, Augustine J, Rehfeld R, Wild A, Abraham I.
    J Manag Care Spec Pharm; 2016 Jan 01; 22(1):40-8. PubMed ID: 27015050
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study.
    Kang JH, Kao LT, Lin HC, Wang TJ, Yang TY.
    PLoS One; 2018 Jan 01; 13(6):e0199981. PubMed ID: 29953536
    [Abstract] [Full Text] [Related]

  • 13. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
    Cheng J, Zhang W, Zhang X, Han F, Li X, He X, Li Q, Chen J.
    JAMA Intern Med; 2014 May 01; 174(5):773-85. PubMed ID: 24687000
    [Abstract] [Full Text] [Related]

  • 14. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
    Toh S, Reichman ME, Houstoun M, Ross Southworth M, Ding X, Hernandez AF, Levenson M, Li L, McCloskey C, Shoaibi A, Wu E, Zornberg G, Hennessy S.
    Arch Intern Med; 2012 Nov 12; 172(20):1582-9. PubMed ID: 23147456
    [Abstract] [Full Text] [Related]

  • 15. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
    Wang Z, Zhang D, Wang S, Jin Y, Huan J, Wu Y, Xia C, Li Z, Qi X, Zhang D, Han X, Zhu X, Qu Y, Wang Q.
    Med Sci Monit; 2020 Sep 24; 26():e926651. PubMed ID: 32969367
    [Abstract] [Full Text] [Related]

  • 16. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury.
    Brar S, Ye F, James MT, Hemmelgarn B, Klarenbach S, Pannu N, Interdisciplinary Chronic Disease Collaboration.
    JAMA Intern Med; 2018 Dec 01; 178(12):1681-1690. PubMed ID: 30422153
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J, Lee S.
    Pharmacotherapy; 2018 Nov 01; 38(11):1095-1105. PubMed ID: 30225928
    [Abstract] [Full Text] [Related]

  • 19. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G, Annis IE, Farley JF, Mahendraratnam N, Hickson RP, Stürmer T, Robinson JG.
    Pharmacotherapy; 2018 Jan 01; 38(1):29-41. PubMed ID: 29059475
    [Abstract] [Full Text] [Related]

  • 20. Melanoma and Non-Melanoma Skin Cancer Associated with Angiotensin-Converting-Enzyme Inhibitors, Angiotensin-Receptor Blockers and Thiazides: A Matched Cohort Study.
    Nardone B, Majewski S, Kim AS, Kiguradze T, Martinez-Escala EM, Friedland R, Amin A, Laumann AE, Edwards BJ, Rademaker AW, Martini MC, West DP.
    Drug Saf; 2017 Mar 01; 40(3):249-255. PubMed ID: 27943160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.